Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 110   

Articles published

JNJ 98.47 0.00 (0.00%)
price chart
GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche ...
New takeover rumors for GlaxoSmithKline Plc. (ADR) (NYSE:GSK) emerged Monday. Daily Mail UK reported that UK dealers were speculating Roche Holding Ltd.
Johnson & Johnson Goes Back to Campus for New Hires
At Johnson & Johnson JNJ -0.03%, an experiment in data analytics has sent some recruiters back to campus. During 2012 and 2013, the health and consumer product giant cut back on hiring fresh college graduates and M.B.
Interesting September Stock Options for Johnson & Johnson
So unless Johnson & Johnson sees its shares fall 5.6% and the contract is exercised (resulting in a cost basis of $94.09 per share before broker commissions, subtracting the 91 cents from $95), the only upside to the put seller is from collecting that ...
Johnson & Johnson Launches App That Will Tell You When Your Neighbors Are ...
As reported by Mashable, McNeil Consumer Healthcare, a division of Johnson & Johnson, has recently released an app that can tell you who in your surrounding area might be stricken with the cold, flu, or allergies.
New app tracks the flu and allergies coming for you only blocks away  Mashable
Search this site:  MobiHealthNews
Is This Johnson & Johnson's Next Blockbuster?
Last month, Johnson & Johnson unveiled its rough outline to file new drug applications for 10 novel blockbusters between 2015 and 2019.
Will Incoming Threats Sink Johnson & Johnson?
Johnson & Johnson (NYSE:JNJ) is a massive cruise ship in the pharmaceutical industry, but there are plenty of fast-moving sharks skimming around its waters.
Johnson & Johnson (JNJ): Strong Drug Pipeline May Reap Benefits  Bidness ETC
The 1 Johnson & Johnson Number You Should Know
In Johnson & Johnson's (NYSE:JNJ) latest earnings report, they announced yet another dividend increase. This, of course, came as little surprise, as Johnson & Johnson is a Dividend Aristocrat -- an elite group of S&P 500 companies that have increased ...
Johnson & Johnson Announces Open Translational Science Project in ...
The OPTICS project will foster collaboration among qualified researchers in the analyses of Janssen's clinical trial data about schizophrenia therapies made available by Johnson & Johnson through the YODA project ( ...
Johnson & Johnson, Union Pacific Corporation, Mastercard Inc: Stock Picks For ...
The pharma arm of Johnson & Johnson is often overlooked for the company's consumer products. But the company believes it can create 10 new drugs by 2019 that have the potential to generate over a billion dollars in sales each.
The Johnson & Johnson Numbers You Should Know
In the case of Johnson & Johnson (NYSE:JNJ), a behemoth blue chip known for stable dividends and deep product pipelines, there are a few key numbers that you have to keep an eye on before Q2 results are reported.